Anzeige
Mehr »
Login
Montag, 04.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CYXP | ISIN: NL0015000F41 | Ticker-Symbol: 5KD
Stuttgart
04.11.24
21:13 Uhr
0,075 Euro
0,000
0,00 %
Branche
Luftfahrt/Rüstung
Aktienmarkt
Sonstige
1-Jahres-Chart
LILIUM NV Chart 1 Jahr
5-Tage-Chart
LILIUM NV 5-Tage-Chart
RealtimeGeldBriefZeit
0,0610,07921:50
0,0000,00001.11.
GlobeNewswire (Europe)
1.394 Leser
Artikel bewerten:
(2)

Lilium N.V.: Lilium expands POWER-ON, creating Comprehensive Solutions Portfolio with Leading Digital Innovators

FARNBOROUGH, United Kingdom, July 21, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (Nasdaq: LILM), a leading electric aircraft manufacturer and pioneer in Regional Air Mobility (RAM), today announced the next phase of its "POWER-ON" Aftermarket Services portfolio, providing a suite of digital solutions to ensure efficient and seamless operation of the Lilium Jet.

The digital suite includes flight planning and aircraft performance ground and Electronic Flight bag solutions, a customer portal with access to technical publications and health monitoring and other ground operations and safety solutions for its customer base. The portal will integrate AI functions for more efficient workflows. These digital systems represent another step towards the Lilium Jet's planned entry into service in 2026 and reflect the importance of robust digital systems for safe and efficient operations. It represents an integral part of the company's industry-first service organization, Lilium POWER-ON, which will provide a full portfolio of services for all aspects of the daily operations of the aircraft.

Initial partners are already contributing to Lilium's flight test campaign as part of the first phase. This includes Microsoft's Azure cloud solution for monitoring the health of the aircraft for flight test clearance. As development continues, the offering will expand to integrate additional critical capabilities for efficient flight planning for the Lilium Jet leveraging proprietary algorithms for Lilium's energy and propulsion systems, and ground operations/vertiport management systems suitable for various types of landing sites and operating models.

"POWER-ON" aims to also develop and offer solutions for passenger check-in and biometric vertiport security screening, working with Amadeus, a leading travel technology company to integrate with Amadeus' existing wide range of airport IT solutions, and also ensure that Amadeus' global reservation and distribution systems can be used for eVTOL operations.

It will also include Flight Data Monitoring via GE Aerospace's Event Management System for safety management and training improvement. Additionally, customers will be able to access technical documents and ask for engineering support through a dedicated customer portal-which will integrate AI functions for more efficient workflows.

Lilium POWER-ON is Lilium's services offering for customers and partners, comprising battery management, maintenance, flight operations, training, and digital solutions. Announced earlier this year, Lilium POWER-ON ensures that Lilium partners can access the resources they need while enabling seamless, efficient services and robust aftermarket products. Further partnerships for Lilium's digital portfolio will be announced shortly.

Sebastien Borel, Chief Commercial Officer of Lilium, said: "We are thrilled to be developing a comprehensive digital portfolio that will set new standards in the Regional Air Mobility market and to be working with such esteemed partners. Our goal is to ensure that every aspect of operating the Lilium Jet is as efficient, safe, and seamless as possible: our unique Lilium POWER-ON offering, which now includes this rich portfolio of essential operational solutions, ensures our operators can access an incredibly comprehensive suite of services for Lilium Jet operations. Leveraging the unique capabilities of our digital partners ensures that we can benefit from established best-in-class solutions that our operators are already familiar with."

Contact information for media:
Christine Pierk
Communications Manager
+49 151 539 199 45
press@lilium.com

Contact information for investors:
Rama Bondada,
Vice President, Investor Relations
Investors@lilium.com

About Lilium
Lilium (NASDAQ: LILM) is creating a sustainable and accessible mode of high-speed, regional transportation for people and goods. Using the Lilium Jet, an all-electric vertical take-off and landing jet, designed to offer leading capacity, low noise, and high performance with zero operating emissions, Lilium is accelerating the decarbonization of air travel. Working with aerospace, technology, and infrastructure leaders, and with announced sales and indications of interest in Europe, the United States, China, Brazil, the UK, the United Arab Emirates, and the Kingdom of Saudi Arabia, Lilium's 1,000+ strong team includes approximately 500 aerospace engineers and a leadership team responsible for delivering some of the most successful aircraft in aviation history. Founded in 2015, Lilium's headquarters and manufacturing facilities are in Munich, Germany, with teams based across Europe and the U.S. To learn more, visit www.lilium.com.

Lilium Forward Looking Statements

This press release contains certain forward-looking statements within the meaning of the U.S. federal securities laws, including, but not limited to, statements regarding: (i) Lilium N.V.'s and its subsidiaries (collectively, the "Lilium Group") proposed business and business model; (ii) the markets and industry in which the Lilium Group operates or intends to operate; (iii) the Lilium Group's progress towards type certification (and type certificate validation) of its Lilium Jet with EASA and the FAA; and (iv) the Lilium Group's partnerships with Microsoft, Amadeus, and GE Aerospace, as discussed herein. These forward-looking statements generally are identified by the words "anticipate," "believe," "could," "expect," "estimate," "future," "intend," "may," "on track," "plan," "project," "should," "strategy," "will," "would" and similar expressions. Forward-looking statements are predictions, projections, and other statements about future events that are based on management's current expectations with respect to future events and are based on assumptions and are subject to risk and uncertainties that are subject to change at any time. Actual events or results may differ materially from those contained in the forward-looking statements. Factors that could cause actual future events to differ materially from the forward-looking statements in this press release include those risks and uncertainties discussed in Lilium's filings with the U.S. Securities and Exchange Commission (the "SEC"), including in the section titled "Risk Factors" in our Annual Report on Form 20-F for the year ended December 31, 2023, on file with the SEC, and similarly titled sections in Lilium's other SEC filings, all of which are available at www.sec.gov. Forward-looking statements speak only as of the date they are made. You are cautioned not to put undue reliance on forward-looking statements, and Lilium assumes no obligation to, and does not intend to, update, or revise these forward-looking statements, whether as a result of new information, future events or otherwise.


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.